News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
August 6, 2025
·
10 min read
Press Releases
Medexus Schedules First Fiscal Quarter 2026 Conference Call
August 6, 2025
·
3 min read
Press Releases
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference
August 6, 2025
·
4 min read
Press Releases
CellCentric to Participate in Upcoming Investor Conferences
August 5, 2025
·
1 min read
Press Releases
GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS’s Fiscal Year 2026
August 5, 2025
·
1 min read
Press Releases
AquaBounty Technologies Announces Second Quarter 2025 Financial Results
August 5, 2025
·
1 min read
Press Releases
BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships
August 5, 2025
·
4 min read
Press Releases
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
August 4, 2025
·
2 min read
Press Releases
Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines
August 4, 2025
·
8 min read
Press Releases
Hemostemix Increases Previously Closed Private Placement to $3,000,000
July 31, 2025
·
9 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us